Jingfang Ju

Jingfang Ju, PhD, is a Professor at Stony Brook University and Co-Founder of iNanoRNA Therapeutics. With over two decades of pioneering research in RNA biology and cancer genomics, his work focuses on developing novel microRNA-based therapeutics. Dr. Ju’s distinguished career includes previous leadership roles at the Mitchell Cancer Institute and CuraGen Corporation. He leverages his extensive expertise in translational science to bridge the gap between academic discovery and clinical application, aiming to create new treatments for cancer and other diseases. He holds a PhD from the University of Southern California and completed postdoctoral training at Yale.